A Clinical Trial of Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed(DTcP)

Inclusion Criteria: * 2 months of age (60\~89 days), 3 months of age (90\~119 days), willing to provide identification documents * The legal guardian or delegate has given informed consent, voluntarily signed the informed consent form, and can comply with the requirements of the clinical study protocol Exclusion Criteria: * Infants 2 months of age who have received a vaccine containing the components of diphtheria, IPV, Hib, or 13-valent pneumococcal polysaccharide conjugate vaccine * Infants 3 months of age who have received vaccines containing diphtheria, Hib, or 13-valent pneumococcal polysaccharide conjugate vaccine or group A, group C meningococcal conjugate vaccine * 3-month-old infant vaccinated with IPV * Premature birth (delivery before the 37th week of gestation), low birth weight (birth weight \<2500g) for 2-month-old (60-89 days) and 3-month-old (90-119 days) infants * History of abnormal labor, asphyxia, and neurological damage * Those who have suffered from pertussis, diphtheria or tetanus * Individuals who have had household contact with individuals with confirmed pertussis, diphtheria, or tetanus disease in the past 30 days * History of allergy to vaccines or vaccine components, severe side effects to vaccines such as allergy, urticaria, respiratory distress, angioneurotic edema * Those with a history of epilepsy, convulsions, convulsions, cerebral palsy, or a history of mental illness or family history; or other progressive neurological disorders * Have be…